MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 196 filers reported holding MIRATI THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.46 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $272,604 | -42.9% | 7,332 | +3.3% | 0.15% | -32.6% |
| Q2 2022 | $477,000 | +118.8% | 7,101 | +377.2% | 0.22% | +98.2% |
| Q4 2021 | $218,000 | -25.3% | 1,488 | -41.8% | 0.11% | -43.6% |
| Q2 2020 | $292,000 | +4071.4% | 2,558 | +2621.3% | 0.20% | +9650.0% |
| Q3 2019 | $7,000 | -88.1% | 94 | -83.7% | 0.00% | -90.9% |
| Q2 2019 | $59,000 | – | 577 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $688,784,000 | 67.42% |
| Avoro Capital Advisors LLC | 4,535,000 | $996,067,000 | 17.15% |
| Darwin Global Management, Ltd. | 260,876 | $57,299,000 | 15.99% |
| Boxer Capital, LLC | 1,765,560 | $387,788,000 | 12.46% |
| Perceptive Advisors | 3,693,516 | $811,244,000 | 8.71% |
| Consonance Capital Management LP | 330,000 | $72,481,000 | 6.77% |
| EcoR1 Capital, LLC | 464,298 | $101,978,000 | 5.48% |
| Fairmount Funds Management LLC | 60,500 | $13,288,000 | 4.75% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,400 | $14,804,000 | 4.04% |
| RTW INVESTMENTS, LP | 1,054,364 | $231,581,000 | 3.88% |